Correction to: A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-XL

被引：0
|
作者：
Jung Jin Hwang
Yong Sook Kim
Taelim Kim
Mi Joung Kim
In Gab Jeong
Je-Hwan Lee
Jene Choi
Sejin Jang
Seonggu Ro
Choung-Soo Kim
机构：
[1] University of Ulsan College of Medicine,Department of Convergence Medicine
[2] Asan Medical Center,Institute for Innovative Cancer Research
[3] University of Ulsan College of Medicine,Department of Urology
[4] Asan Medical Center,Department of Internal Medicine & Laboratory Medicine
[5] University of Ulsan College of Medicine,Department of Pathology
[6] Asan Medical Center,undefined
[7] University of Ulsan College of Medicine,undefined
[8] Asan Medical Center,undefined
[9] University of Ulsan College of Medicine,undefined
[10] Asan Medical Center,undefined
[11] PiMedBio,undefined
[12] Inc.,undefined
来源：
Investigational New Drugs | 2019年 / 37卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The blots of control and docetaxel for caspase-9, caspase-3, caspase-8, Bcl-XL, and tubulin in the Figure 4f were reused from Figure 4 of our previous paper published in Journal of Urology in 2010 (https://doi.org/10.1016/j.juro.2010.07.035).
引用
收藏
页码：796 / 796
相关论文
共 32 条
  • [21] Bcl-2/Bcl-xL inhibitor navitoclax increases the antitumor effect of Chk1 inhibitor prexasertib by inducing apoptosis in pancreatic cancer cells via inhibition of Bcl-xL but not Bcl-2
    Morimoto, Yoshihito
    Takada, Kimihiko
    Takeuchi, Osamu
    Watanabe, Kazuhiro
    Hirohara, Masayoshi
    Hamamoto, Tomoyuki
    Masuda, Yutaka
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2020, 472 (1-2) : 187 - 198
  • [22] Paclitaxel in combination with AT-101 induces apoptosis via supressing Bcl-2, bcl-XL, mcl-1 proteins in human breast cancer cells.
    Cakar, Burcu
    Gursoy, Pinar
    Atmaca, Harika
    Kisim, Asli
    Bozkurt, Emir
    Uzunoglu, Selim
    Sezgin, Canfeza
    Sanli, Ulus Ali
    Karabulut, Bulent
    Uslu, Ruchan
    Karaca, Burcak
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [23] Preclinical Studies of Apogossypolone, a Novel Pan Inhibitor of Bcl-2 and Mcl-1, Synergistically Potentiates Cytotoxic Effect of Gemcitabine in Pancreatic Cancer Cells
    Banerjee, Sanjeev
    Choi, Minsig
    Aboukameel, Amro
    Wang, Zhiwei
    Mohammad, Mussop
    Chen, Jianyong
    Yang, Dajun
    Sarkar, Fazlul H.
    Mohammad, Ramzi M.
    PANCREAS, 2010, 39 (03) : 323 - 331
  • [24] Induction of Noxa Sensitizes Human Colorectal Cancer Cells Expressing Mcl-1 to the Small-Molecule Bcl-2/Bcl-XL Inhibitor, ABT-737
    Okumura, Kenji
    Huang, Shengbing
    Sinicrope, Frank A.
    CLINICAL CANCER RESEARCH, 2008, 14 (24) : 8132 - 8142
  • [25] POST-TREATMENT WITH HISTONE DEACETYLASE INHIBITOR POTENTIATES THE ANTI-TUMOR EFFECT OF DOCETAXEL IN ANDROGEN-INDEPENDENT PROSTATE CANCER CELLS
    Kwon, Taekmin
    Hwang, Jung Jin
    Kim, Yong-Sook
    Kim, Mi-Joung
    Jeong, In Gab
    Kim, Choung-Soo
    JOURNAL OF UROLOGY, 2009, 181 (04): : 477 - 478
  • [26] Mcl-1 levels critically impact the sensitivities of human colorectal cancer cells to APG-1252-M1, a novel Bcl-2/Bcl-XL dual inhibitor that induces Bax-dependent apoptosis
    Yao, Weilong
    Bai, Longchuan
    Wang, Shaomeng
    Zhai, Yifan
    Sun, Shi-Yong
    NEOPLASIA, 2022, 29
  • [27] Low dose histone deacetylase inhibitor, LBH589, potentiates anticancer effect of docetaxel in epithelial ovarian cancer via PI3K/Akt pathway in vitro
    Chao, Hongtu
    Wang, Li
    Hao, Jingli
    Ni, Jie
    Chang, Lei
    Graham, Peter H.
    Kearsley, John H.
    Li, Yong
    CANCER LETTERS, 2013, 329 (01) : 17 - 26
  • [28] The Effects of Thymoquinone on Viability, and Anti-apoptotic Factors (BCL-XL, BCL-2, MCL-1) in Prostate Cancer (PC3) Cells: An In Vitro and Computer-Simulated Environment Study
    Saffari-Chaleshtori, Javad
    Heidari-Sureshjani, Ehsan
    Moradi, Fahimeh
    Heidarian, Esfandiar
    ADVANCED PHARMACEUTICAL BULLETIN, 2019, 9 (03) : 490 - 496
  • [29] Gemcitabine and APG-1252, a novel small molecule inhibitor of BCL-2/BCL-XL, display a synergistic antitumor effect in nasopharyngeal carcinoma through the JAK-2/STAT3/MCL-1 signaling pathway
    Fan Luo
    Fei-Teng Lu
    Miao-Zhen Qiu
    Ting Zhou
    Wen-Juan Ma
    Min Luo
    Kang-Mei Zeng
    Qiu-Yun Luo
    Wen-Tao Pan
    Lin Zhang
    Zeng-Fei Xia
    Zhong-Han Zhang
    Jia-Xin Cao
    Hong-Yun Zhao
    Li Zhang
    Da-Jun Yang
    Cell Death & Disease, 12
  • [30] Gemcitabine and APG-1252, a novel small molecule inhibitor of BCL-2/BCL-XL, display a synergistic antitumor effect in nasopharyngeal carcinoma through the JAK-2/STAT3/MCL-1 signaling pathway
    Luo, Fan
    Lu, Fei-Teng
    Qiu, Miao-Zhen
    Zhou, Ting
    Ma, Wen-Juan
    Luo, Min
    Zeng, Kang-Mei
    Luo, Qiu-Yun
    Pan, Wen-Tao
    Zhang, Lin
    Xia, Zeng-Fei
    Zhang, Zhong-Han
    Cao, Jia-Xin
    Zhao, Hong-Yun
    Zhang, Li
    Yang, Da-Jun
    CELL DEATH & DISEASE, 2021, 12 (08)
1234